News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
104,905 Results
Type
Article (4170)
Company Profile (41)
Press Release (100694)
Multimedia
Podcasts (4)
Webinars (3)
Section
Business (34298)
Career Advice (85)
Deals (6435)
Drug Delivery (9)
Drug Development (11998)
Employer Resources (10)
FDA (2209)
Job Trends (1600)
News (55510)
Policy (4509)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (237)
Allergies (10)
Alliances (11156)
ALS (8)
Alzheimer's disease (162)
Antibody-drug conjugate (ADC) (22)
Approvals (2234)
Artificial intelligence (24)
Autoimmune disease (3)
Automation (2)
Bankruptcy (19)
Best Places to Work (1110)
BIOSECURE Act (2)
Biosimilars (31)
Biotechnology (34)
Bladder cancer (13)
Brain cancer (6)
Breast cancer (42)
Cancer (337)
Cardiovascular disease (10)
Career advice (72)
Career pathing (1)
CAR-T (17)
Cell therapy (65)
Cervical cancer (2)
Clinical research (9956)
Collaboration (175)
Compensation (57)
Complete response letters (2)
COVID-19 (342)
CRISPR (7)
C-suite (42)
Cystic fibrosis (6)
Data (291)
Denatured (3)
Depression (4)
Diabetes (21)
Diagnostics (1011)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (26)
Drug pricing (7)
Duchenne muscular dystrophy (24)
Earnings (11571)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (12909)
Executive appointments (141)
FDA (2394)
Featured Employer (4)
Fibrodysplasia Ossificans Progressiva (1)
Funding (131)
Gene editing (17)
Gene therapy (36)
GLP-1 (97)
Government (366)
Grass and pollen (1)
Guidances (4)
Healthcare (1757)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (17)
Indications (5)
Infectious disease (354)
Inflammatory bowel disease (27)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (25)
Interviews (7)
IPO (2532)
IRA (7)
Job creations (517)
Job search strategy (70)
Kidney cancer (4)
Labor market (4)
Layoffs (42)
Leadership (1)
Legal (1135)
Liver cancer (20)
Lung cancer (45)
Lymphoma (14)
Management (4)
Manufacturing (47)
MASH (10)
Medical device (1460)
Medtech (1461)
Mergers & acquisitions (4060)
Metabolic disorders (68)
Multiple sclerosis (14)
NASH (1)
Neurodegenerative disease (15)
Neuropsychiatric disorders (3)
Neuroscience (245)
NextGen: Class of 2025 (547)
Non-profit (212)
Northern California (464)
Now hiring (4)
Obesity (31)
Opinion (16)
Ovarian cancer (20)
Pain (13)
Pancreatic cancer (11)
Parkinson's disease (19)
Partnered (4)
Patents (38)
Patient recruitment (11)
Peanut (1)
People (10122)
Pharmaceutical (8)
Phase I (3212)
Phase II (4394)
Phase III (3427)
Pipeline (186)
Policy (12)
Postmarket research (272)
Preclinical (1252)
Press Release (4)
Prostate cancer (11)
Psychedelics (2)
Radiopharmaceuticals (33)
Rare diseases (47)
Real estate (989)
Recruiting (5)
Regulatory (3320)
Reports (10)
Research institute (233)
Resumes & cover letters (9)
Schizophrenia (14)
Series A (38)
Series B (10)
Service/supplier (3)
Sickle cell disease (2)
Southern California (500)
Special edition (1)
Spinal muscular atrophy (6)
Sponsored (1)
Startups (871)
Stomach cancer (2)
Supply chain (11)
The Weekly (1)
United States (2931)
Vaccines (49)
Venture capitalists (9)
Weight loss (14)
Women's health (2)
Worklife (1)
Date
Today (17)
Last 7 days (93)
Last 30 days (434)
Last 365 days (5373)
2025 (1488)
2024 (5683)
2023 (6498)
2022 (10344)
2021 (10040)
2020 (8770)
2019 (5792)
2018 (4452)
2017 (5200)
2016 (4668)
2015 (5706)
2014 (4307)
2013 (3717)
2012 (4136)
2011 (4174)
2010 (3741)
Location
Africa (119)
Alabama (2)
Arizona (22)
Asia (22480)
Australia (2611)
California (1122)
Canada (368)
China (172)
Colorado (25)
Connecticut (22)
Delaware (9)
Europe (15590)
Florida (65)
Georgia (9)
Idaho (5)
Illinois (30)
India (12)
Indiana (35)
Japan (77)
Kansas (17)
Louisiana (1)
Maine (4)
Maryland (99)
Massachusetts (524)
Michigan (10)
Minnesota (37)
Missouri (6)
Nebraska (2)
Nevada (4)
New Hampshire (2)
New Jersey (257)
New York (189)
North Carolina (146)
Northern California (464)
Ohio (27)
Oklahoma (2)
Oregon (5)
Pennsylvania (100)
Rhode Island (2)
South America (145)
South Carolina (1)
Southern California (500)
Tennessee (3)
Texas (99)
Utah (14)
Virginia (30)
Washington D.C. (3)
Washington State (64)
Wisconsin (12)
104,905 Results for "hummingbird bioscience pte ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
Press Releases
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
January 7, 2025
·
2 min read
Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
Data highlights potential of Hummingbird Bioscience’s dual-payload antibody-drug conjugate platform to improve upon the current generation of ADCs
May 13, 2024
·
4 min read
Press Releases
Hummingbird Bioscience Announces Key Leadership Appointments
July 29, 2024
·
2 min read
BioCapital
Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024
Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024.
March 13, 2024
·
4 min read
Business
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
Hummingbird Bioscience announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately.
December 11, 2023
·
2 min read
Biotech Bay
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024
Hummingbird Bioscience announced two upcoming poster presentations at the American Association for Cancer Research Meeting 2024 in San Diego, California.
March 5, 2024
·
6 min read
Press Releases
Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024
October 24, 2024
·
2 min read
Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024
SINGAPORE and HANOVER, March 13, 2024 – Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine today announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024 (11:00 AM - 3:30 PM ET).
March 13, 2024
·
4 min read
Business
Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
Hummingbird Bioscience and Endeavor BioMedicines (“Endeavor”), a clinical-stage company targeting the drivers of fibrosis and oncology, today announced that Endeavor has acquired exclusive worldwide rights to Hummingbird Bio’s antibody-drug conjugate (ADC), HMBD-501.
October 19, 2023
·
4 min read
1 of 10,491
Next
